275 filings
Page 4 of 14
8-K
8p8px5b3 uwg
13 Jan 20
Other Events
5:19pm
8-K
zb2aitgijj8zboloh49
6 Nov 19
Vanda Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:06pm
8-K
o3p4efnb 3ci6t1fw
28 Oct 19
Vanda Pharmaceuticals Appoints Anne Sempowski Ward to Board of Directors
4:55pm
8-K
lx2zj3pgf8n491r
19 Aug 19
Vanda Pharmaceuticals FDA Update for HETLIOZĀ® in the Treatment of Jet Lag Disorder
7:09am
8-K
nucxu
31 Jul 19
Vanda Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:05pm
8-K
v2y3 ozqndjb
22 Jul 19
Vanda Pharmaceuticals FDA Update for HETLIOZĀ® in the Treatment of Jet Lag Disorder
8:35am
8-K
q1lpt45ckh
16 Jul 19
Other Events
5:25pm
8-K
ngpnclp lta1nqhl7
13 Jun 19
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
v94t730j9u
10 Jun 19
Other Events
4:32pm
8-K
tsk5prskcydttjw4hm
9 May 19
Other Events
4:32pm
8-K
dqpn5lxyn h788epq
1 May 19
Vanda Pharmaceuticals Reports First Quarter 2019 Financial Results
4:05pm
8-K
2isi09f
30 Apr 19
Other Events
8:30am
8-K
wdthgeolbx
24 Apr 19
Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors
4:36pm
8-K
z0hl5
1 Mar 19
Departure of Directors or Certain Officers
8:30am
8-K
u6ez oh8juxp
13 Feb 19
Vanda Pharmaceuticals Reports Fourth Quarter 2018 and Full Year
4:09pm
8-K
itis 5avv
6 Feb 19
Regulation FD Disclosure
6:07am
8-K
ktaukmep
10 Dec 18
Vanda Announces Positive Pivotal Study Results for HETLIOZĀ® (tasimelteon) in Patients with Smith-Magenis Syndrome
4:31pm
8-K
d2lv43d20xa 1d6
3 Dec 18
Vanda Announces Positive Phase II Study Results for Tradipitant in Patients with Gastroparesis
4:32pm
8-K
ryw9hmq6dy8 sqej1w
7 Nov 18
Vanda Pharmaceuticals Reports Third Quarter 2018 Financial Results
4:06pm
8-K
d1csijt00x3 8rs3oc
4 Oct 18
Other Events
4:31pm